RIGEL PHARMACEUTICALS INC (RIGL) Stock Price, Quote, News and Overview
NASDAQ:RIGL - Nasdaq - US7665597024 - Common Stock - Currency: USD
RIGL Quote, Performance and Key Statistics
RIGEL PHARMACEUTICALS INC
NASDAQ:RIGL (1/27/2025, 8:23:40 PM)
After market: 21.72 0 (0%)21.72
-0.45 (-2.03%)
The current stock price of RIGL is 21.72 USD. In the past month the price increased by 32.12%. In the past year, price increased by 90.53%.
RIGL Latest News, Press Releases and Analysis
Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating the safety and...
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz
The intense retail focus on Anavex reflects a broader market interest in neurodegenerative therapies, especially following disappointing trial results from Cassava Sciences’ simufilam.
Rigel Provides Business Update and 2025 Outlook
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today...
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today...
Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today...
RIGL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.46 | 312.61B | ||
| AMGN | AMGEN INC | 14.72 | 152.09B | ||
| GILD | GILEAD SCIENCES INC | 21.52 | 118.83B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 870.35 | 114.31B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.07 | 75.24B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.80B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.69B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.86B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.98B | ||
| NTRA | NATERA INC | N/A | 21.82B | ||
| BIIB | BIOGEN INC | 9.11 | 21.68B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.34B |
Related stock screener links
About RIGL
Company Profile
Rigel Pharmaceuticals Inc is a US-based company operating in Biotechnology industry. The company is headquartered in South San Francisco, California and currently employs 147 full-time employees. The company went IPO on 2000-11-29. Rigel Pharmaceuticals, Inc. is a biotechnology company. The firm is engaged in developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. The company is focused on products that address signaling pathways that are critical to disease mechanisms. Its first product is TAVALISSE (fostamatinib disodium hexahydrate) tablets, the approved oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Its second product is REZLIDHIA (olutasidenib) capsules for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. Its GAVRETO (pralsetinib) product is a once daily, small molecule, oral, kinase inhibitor of wild type rearranged during transfection (RET) and oncogenic RET fusions.
Company Info
RIGEL PHARMACEUTICALS INC
611 Gateway Boulevard, Suite 900
South San Francisco CALIFORNIA 94080 US
CEO: Raul R. Rodriguez
Employees: 147
Company Website: https://www.rigel.com/
Investor Relations: https://www.rigel.com/investors
Phone: 16506241100
RIGL FAQ
What is the stock price of RIGL?
The current stock price of RIGL is 21.72 USD.
What is the symbol for RIGEL PHARMACEUTICALS INC stock?
The exchange symbol of RIGEL PHARMACEUTICALS INC is RIGL and it is listed on the Nasdaq exchange.
On which exchange is RIGL stock listed?
RIGL stock is listed on the Nasdaq exchange.
Is RIGL a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for RIGL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of RIGL.
Does RIGL stock pay dividends?
RIGL does not pay a dividend.
What is the Price/Earnings (PE) ratio of RIGL?
The PE ratio for RIGL is 155.14. This is based on the reported non-GAAP earnings per share of 0.14 and the current share price of 21.72 USD.
What is the Short Interest ratio of RIGL stock?
The outstanding short interest for RIGL is 4.69% of its float.
RIGL Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to RIGL. When comparing the yearly performance of all stocks, RIGL is one of the better performing stocks in the market, outperforming 95.3% of all stocks.
RIGL Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to RIGL. RIGL has a medium profitability rating, but doesn't score so well on its financial health evaluation.
RIGL Financial Highlights
Over the last trailing twelve months RIGL reported a non-GAAP Earnings per Share(EPS) of 0.14. The EPS increased by 110% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.46% | ||
| ROA | 2.78% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
RIGL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 77% to RIGL. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 119.54% and a revenue growth 49.74% for RIGL